TAYLOR MORRIS: Open Payments
NPI 1497488183 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 95 payments from 17 companies in 2025. Trend: 2023 $2,004 · 2024 $2,061 · 2025 $1,570
Food & beverage: $1,570
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $218 |
| Novo Nordisk Inc | 11 | $199 |
| ABBVIE INC. | 15 | $190 |
| GlaxoSmithKline, LLC. | 9 | $158 |
| Abbott Laboratories | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| Lilly USA, LLC | 5 | $89 |
| Lundbeck LLC | 5 | $80 |
| Amgen Inc. | 5 | $79 |
| Novartis Pharmaceuticals Corporation | 5 | $75 |
Products named: Korlym, VRAYLAR, Wegovy, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Kerendia, VYEPTI, OTEZLA.
Industry payments across NJ — which companies pay providers there.
